Achnil Tablet 200 mg

Achnil Tablet is a non-steroidal anti-inflammatory drug (NSAID) containing Tolfenamic Acid 200 mg. Manufactured by Desh Pharmaceuticals Ltd, it effectively treats migraine headaches, postoperative pain, and fever-related discomfort. Priced at ৳8.00 per unit, the strip costs ৳80.00, while a pack of 30 tablets is available for ৳240.00.

This tablet inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis to alleviate inflammation and pain. It achieves peak plasma concentration within 60-90 minutes and has 85% bioavailability. With 99% protein-binding and a 2-hour half-life, it’s metabolized in the liver and excreted via urine (90%). Store in a cool, dry place away from light and children.

Dosage varies: 200 mg for acute migraines (repeatable after 1-2 hours) and 100-200 mg thrice daily for mild-to-moderate pain. Avoid use in severe kidney impairment. Drug interactions include increased bleeding risk with anticoagulants and reduced efficacy of antihypertensives. Common side effects include diarrhea, nausea, and epigastric pain.

LSI Keywords: Achnil Tablet 200 mg, Desh Pharmaceuticals Ltd Achnil Tablet, Achnil Tablet price, Tolfenamic acid uses. Pregnant women and lactating mothers should avoid it unless absolutely necessary. Overdose may cause gastrointestinal bleeding or renal dysfunction.

Adults: 200 mg initially for acute migraine, repeat after 1-2 hours if needed. Mild pain: 100-200 mg thrice daily. Renal impairment requires dose adjustment. Take with food. Avoid prolonged use beyond 7 days without medical supervision.

Side effects which include rare alveolitis, hepatic damage, pancreatitis, pulmonary eosinophilia, Stevens-johnson syndrome, angioedema, blood disorder, depression, diarrhea, dizziness, drowsiness, dysuria, euphoria, gastro-intestinal bleeding, gastro-intestinal discomfort, hallucination, insomnia, malaise, nausea, hearing disturbances, rash, visual disturbances , vertigo, raised blood pressure. Overdose: Symptoms include headache, nausea, vomiting, gastro-intestinal bleeding, drowsiness, dizziness, occasionally convulsion. In case of significant poisoning acute renal failure and liver damage are possible.

Use in pregnancy only if benefits outweigh risks. Contraindicated in third trimester. Avoid during lactation due to potential secretion in breast milk.

Monitor cardiovascular/hepatic patients closely. Regular renal function tests required during prolonged use. Avoid concurrent NSAID combinations.

Elderly and renal-impaired patients need dose reduction. Pediatric safety unestablished. Hepatic impairment requires dosage adjustment.

Symptoms include headache, nausea, vomiting, epigastric pain. gastrointestinal bleeding, diarrhoea excitation, coma, drowsiness dizziness, tinnitus, fainting and convulsions. In cases of significant poisoning, acute renal failure and liver damage are possible. Patients should be treated symptomatically as required.